Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Stip

Showing results (211-220 of 278) with videos related to

Pageof 28
Sort By:
Schizophrenia Research|March 29, 2011
Schizophrenia and serious violence: a clinical-profile analysis incorporating impulsivity and substance-use disordersAlexandre Dumais, Stéphane Potvin, Christian Joyal, et al.
The American Journal of Drug and Alcohol Abuse|December 29, 2007
Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophreniaStéphane Potvin, Emmanuel Stip, Olivier Lipp, et al.
Current Medical Research and Opinion|February 10, 2007
Quetiapine augmentation of treatment-resistant depression: a comparison with lithiumJean-Pierre Dorée, Joël Des Rosiers, Viviane Lew, et al.
Schizophrenia Research|March 24, 2016
Increased ventro-medial prefrontal activations in schizophrenia smokers during cigarette cravingsStéphane Potvin, Ovidiu Lungu, Olivier Lipp, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|June 29, 2026
Healthcare Pattern of Use Before and After Initiating a Long-Acting Antipsychotic Among a Cohort of 6221 Patients With a History of PsychosisEmmanuel Stip, Josiane Courteau, Sébastien Brodeur, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 2, 2011
Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disordersRaouf Igue, Stéphane Potvin, Ramatoulaye Bah, et al.
Journal of Psychopharmacology (Oxford, England)|March 15, 2021
Efficacy of onabotulinumtoxinA in the treatment of unipolar major depression: Systematic review, meta-analysis and meta-regression analyses of double-blind randomised controlled trialsDanilo Arnone, Hassan Galadari, Carl J Rodgers, et al.
Expert Opinion on Pharmacotherapy|October 29, 2010
Clinical evolution of substance use disorder patients during treatment with quetiapine: a 12-week, open-label, naturalistic trialElie Rizkallah, Emmanuel Stip, Simon Zhornitsky, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|September 6, 2021
Urbanicity, Schizophrenia and Equitable Specialist Services AllocationAlain Lesage, Josiane Courteau, Sébastien Brodeur, et al.
Psychiatry Research|August 3, 2013
Cannabis abuse is associated with better emotional memory in schizophrenia: a functional magnetic resonance imaging studyJosiane Bourque, Adrianna Mendrek, Myriam Durand, et al.
Pageof 28

Showing results (211-220 of 278) with videos related to

Sort By:
Pageof 28
Schizophrenia Research|March 29, 2011
Schizophrenia and serious violence: a clinical-profile analysis incorporating impulsivity and substance-use disordersAlexandre Dumais, Stéphane Potvin, Christian Joyal, et al.
The American Journal of Drug and Alcohol Abuse|December 29, 2007
Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophreniaStéphane Potvin, Emmanuel Stip, Olivier Lipp, et al.
Current Medical Research and Opinion|February 10, 2007
Quetiapine augmentation of treatment-resistant depression: a comparison with lithiumJean-Pierre Dorée, Joël Des Rosiers, Viviane Lew, et al.
Schizophrenia Research|March 24, 2016
Increased ventro-medial prefrontal activations in schizophrenia smokers during cigarette cravingsStéphane Potvin, Ovidiu Lungu, Olivier Lipp, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|June 29, 2026
Healthcare Pattern of Use Before and After Initiating a Long-Acting Antipsychotic Among a Cohort of 6221 Patients With a History of PsychosisEmmanuel Stip, Josiane Courteau, Sébastien Brodeur, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 2, 2011
Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disordersRaouf Igue, Stéphane Potvin, Ramatoulaye Bah, et al.
Journal of Psychopharmacology (Oxford, England)|March 15, 2021
Efficacy of onabotulinumtoxinA in the treatment of unipolar major depression: Systematic review, meta-analysis and meta-regression analyses of double-blind randomised controlled trialsDanilo Arnone, Hassan Galadari, Carl J Rodgers, et al.
Expert Opinion on Pharmacotherapy|October 29, 2010
Clinical evolution of substance use disorder patients during treatment with quetiapine: a 12-week, open-label, naturalistic trialElie Rizkallah, Emmanuel Stip, Simon Zhornitsky, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|September 6, 2021
Urbanicity, Schizophrenia and Equitable Specialist Services AllocationAlain Lesage, Josiane Courteau, Sébastien Brodeur, et al.
Psychiatry Research|August 3, 2013
Cannabis abuse is associated with better emotional memory in schizophrenia: a functional magnetic resonance imaging studyJosiane Bourque, Adrianna Mendrek, Myriam Durand, et al.
Pageof 28